News-Medical.Net

Could your birth characteristics influence colorectal cancer risk?

A California study links birth and parental factors to early-onset colorectal cancer risk, highlighting male sex and Hispanic ...
The American Journal of Managed Care

Early-Life, Parental Factors May Help Explain Rising Early-Onset CRC Rates

A nested case-control linkage of California births to cancer registry data captured 1,221 EOCRC cases (diagnosed ages 0–39) and 61,050 frequency-matched controls for multivariable modeling. Male sex ...
Nature

A nested case–control study of risk for pulmonary embolism in the general trauma population using nationwide trauma registry data in Japan

Post-trauma patients are at great risk of pulmonary embolism (PE), however, data assessing specific risk factors for post-traumatic PE are scarce. This was a nested case–control study using the Japan ...
ascopubs.org

Pre-existing Thyroid Autoimmunity and Risk of Papillary Thyroid Cancer: A Nested Case-Control Study of US Active-Duty Personnel

Phase Ib Study of Navicixizumab Plus Paclitaxel in Patients With Platinum-Resistant Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Among 451 incident cases of papillary thyroid cancer and ...
Morning Overview on MSN

Certain antidepressants and sedatives may quietly raise dementia risk in older patients, a study warns

Older adults who take certain antidepressants with anticholinergic properties alongside benzodiazepine sedatives face a ...
Nature

Prediction of coronary heart disease incidence in a general male population by circulating non-coding small RNA sRNY1-5p in a nested case–control study

During the development of atherosclerotic lesion, s-RNYs (small RNAs of about 24/34 nucleotides) are derived by the processing of long Ro-associated non-coding RNAs (RNYs) in macrophages. The levels ...
ascopubs.org

Erratum: Risk Factors for Primary Bone Cancer After Childhood Cancer: A PanCare Childhood and Adolescent Cancer Survivor Care and Follow-Up Studies Nested Case-Control Study

Erratum: Phase II, Open-Label Study of Encorafenib Plus Binimetinib in Patients With BRAFV600-Mutant Metastatic Non–Small-Cell Lung Cancer Risk Factors for Primary Bone Cancer After Childhood Cancer: ...